Long-Term Engraftment (16 Years) of Myoblasts in a Human Infarcted Heart

Author:

Crahès Marie12,Bories Marie-Cécile3,Vilquin Jean-Thomas4,Marolleau Jean-Pierre5,Desnos Michel26,Larghero Jérôme789,Soulat Gilles210,Bruneval Patrick126,Hagège Albert A.2611,Menasché Philippe236

Affiliation:

1. a Department of Pathology Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

2. b University Paris Descartes, Sorbonne Paris Cité, Paris, France

3. c Department of Cardiovascular Surgery Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

4. d Sorbonne Université, INSERM, CNRS, Center of Research in Myology, Institute of Myology, GH Pitié-Salpêtrière, Paris, France

5. e CHU Amiens, Hematology and Cell Therapy Unit, Université Picardie Jules Verne, Amiens, France

6. f INSERM U970, Hôpital Européen Georges Pompidou, Paris, France

7. g Cell Therapy Unit Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Cell Therapy Unit, Paris, France

8. h INSERM, CIC de Biothérapies (CBT-501) and U1160, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France

9. i University Paris Diderot, Sorbonne Paris Cité, Paris, France

10. j Department of Radiology Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

11. k Department of Cardiology Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Abstract

Abstract We report the case of a patient who had undergone injections of myoblasts in an infarct area 16 years before being referred for heart transplantation. The pathological examination of the explanted heart found persisting myotubes embedded in fibrosis. This finding supports the ability of myoblasts to survive in harsh environments, which can make them appealing candidates for transplantation in diseases requiring supply of new myogenic cells.

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,General Medicine

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3